Expanded indications - Verzenio (abemaciclib)

Verzenio (abemaciclib) - expanded indications for: 1) adjuvant treatment of HR-positive HER2-negative, node-positive, early breast cancer at high risk of recurrence, and 2) advanced or metastatic breast CA in adult patients as first-line treatment in combo with aromatase inhibitor.